Residual disease after neoadjuvant therapy - Developing drugs for high-risk early breast cancer

Tatiana M. Prowell; Julia Beaver; Richard Pazdur

doi:10.1056/NEJMp1900079

Residual disease after neoadjuvant therapy - Developing drugs for high-risk early breast cancer

Tatiana M. Prowell, Julia Beaver, Richard Pazdur

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	612-615
Number of pages	4
Journal	New England Journal of Medicine
Volume	380
Issue number	7
DOIs	https://doi.org/10.1056/NEJMp1900079
State	Published - Feb 14 2019
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMp1900079

Cite this

@article{c55f8c8e54884f0d90670a70e1a13db6,

title = "Residual disease after neoadjuvant therapy - Developing drugs for high-risk early breast cancer",

author = "Prowell, {Tatiana M.} and Julia Beaver and Richard Pazdur",

year = "2019",

month = feb,

day = "14",

doi = "10.1056/NEJMp1900079",

language = "English (US)",

volume = "380",

pages = "612--615",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "7",

}

TY - JOUR

T1 - Residual disease after neoadjuvant therapy - Developing drugs for high-risk early breast cancer

AU - Prowell, Tatiana M.

AU - Beaver, Julia

AU - Pazdur, Richard

PY - 2019/2/14

Y1 - 2019/2/14

UR - http://www.scopus.com/inward/record.url?scp=85061565390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061565390&partnerID=8YFLogxK

U2 - 10.1056/NEJMp1900079

DO - 10.1056/NEJMp1900079

M3 - Review article

C2 - 30763188

AN - SCOPUS:85061565390

SN - 0028-4793

VL - 380

SP - 612

EP - 615

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 7

ER -

Residual disease after neoadjuvant therapy - Developing drugs for high-risk early breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this